dailypolitical.com
Neutralwww.dailypolitical.com ·
medicinova mnov expected to announce quarterly earnings on wednesday
TAX_FNCACT_ANALYSTTAX_FNCACT_AGENTTAX_FNCACT_ANALYSTSTAX_DISEASE_ASTHMA
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedRoutine quarterly earnings announcement for a small-cap biotech firm. No new drug approval, pipeline update, or partnership disclosed. The commercial mechanism is limited to potential stock price volatility around earnings miss/beat, but no direct impact on drug pricing, supply chain, or sector-wide margins. Weak commercial signal.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- MediciNova (MNOV) to report Q1 2026 earnings on May 13, 2026 after market close.
- Analysts estimate EPS loss of $0.06 and revenue of $0.128 million.
- Previous quarter (Feb 20, 2026): loss of $0.05 per share, revenue of $0.15 million.
- Stock price $1.41, market cap $69.40 million.
- HC Wainwright rates 'Buy' with $10 target; consensus 'Moderate Buy' with $7.50 target.